Page last updated: 2024-11-01

cm 7116 and Chronic Insomnia

cm 7116 has been researched along with Chronic Insomnia in 1 studies

norflutoprazepam: structure

Research Excerpts

ExcerptRelevanceReference
"Quazepam and flurazepam share pharmacokinetic properties that result in prevention of early-morning insomnia, daytime rebound anxiety, and withdrawal rebound insomnia."2.38Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics. ( Battista, D; Hilbert, JM, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hilbert, JM1
Battista, D1

Reviews

1 review available for cm 7116 and Chronic Insomnia

ArticleYear
Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
    The Journal of clinical psychiatry, 1991, Volume: 52 Suppl

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cricetinae; Flurazepam; Humans; Hy

1991